Actively Recruiting
Comparing Corticosteroid and Platelet-Rich Plasma Injections to Treat Primary Glenohumeral Osteoarthritis
Led by Rush University Medical Center · Updated on 2026-02-17
200
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effectiveness of two types of injectionsintra-articular corticosteroid injections and platelet-rich plasma PRP injectionsfor treating primary glenohumeral osteoarthritis, a form of arthritis affecting the shoulder joint. This trial aims to understand how these commonly used treatments compare in providing symptom relief and potentially delaying or preventing the need for shoulder replacement surgery. The study is a prospective, double-blind, randomized controlled trial sponsored by Rush University Medical Center. Participants will be randomly assigned to receive either an ultrasound-guided injection of 80mg Depo-Medrol with 8cc Lidocaine or an ultrasound-guided injection of PRP prepared from a 15cc blood draw processed using the Arthrex Autologous Conditioned Plasma kit. Each participant will receive only one injection during the study. The trial does not include a placebo group but compares these two active treatments directly. During the study, participants will be monitored for pain relief using the Visual Analog Scale VAS at 12 weeks after injection. Researchers will assess how each treatment impacts pain levels over this period. The study includes careful screening based on medical history and previous treatments, and participants will be followed according to the trial schedule to evaluate outcomes and safety. The total duration of participation varies by individual needs.
CONDITIONS
Brief Title
Efficacy of Intra-articular Injections for the Treatment of Primary Glenohumeral Osteoarthritis(GHOA)
Research Team
C
Carla M Edwards, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here